TOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) — A.D.A.M. Innovations Co. (Japanese Name: Genesis Healthcare Co.) (“A.D.A.M. Innovations” or the “Company”), Japan's leading AI-driven genomics company, today announced the release of three new first-of-their-kind cancer prediction models for its GeneLife GeneAI Forecast platform: breast cancer (women), prostate cancer (men), and pancreatic cancer (unisex), developed using the […]
(NASDAQ:ITRM), DUBLIN and CHICAGO, Dec. 05, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update. Recent Events Market Access
(NASDAQ:ATYR),(NASDAQ:MRX),(NYSE:WPP),(NASDAQ:CPTN), ATLANTA, Dec. 05, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff in the following class action lawsuits: Marex, Inc. (MRX) The shareholder class action lawsuit filed against Marex, Inc. (“Marex” or the “Company”) (NASDAQ: MRX) alleges that Defendants made materially false and/or
Accton, Arista, and Cisco Gained the Most Share, While Celestica and NVIDIA Continue toLead with Nearly 50 Percent Combined Share in the Ethernet Segment According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, security, networks, and data center industries, Ethernet accounted for more than two-thirds of
First-in-human data highlights safety, pharmacodynamics, and single-agent activity supporting MMSET/NSD2 inhibition in heavily pre-treated multiple myeloma patients Shinta Cheng, M.D., Ph.D., joins K36 to drive clinical development of lead programs and oncology pipeline expansion K36 Therapeutics, Inc.(“K36”), a clinical-stage biotechnology company developing first-in-class MMSET/NSD2 inhibitors for genetically defined cancers, today announced that clinical data from
Olympus Corporation (“Olympus”), W. L. Gore & Associates, Inc. (“Gore”), and ConMed Corporation (“ConMed”) jointly announced today the upcoming transition of commercial support and distribution for the GORE® VIABIL® Biliary Endoprosthesis for endoscopic placement (“VIABIL® device”) in the United States. This announcement follows the signed agreement between Gore and Olympus by which the exclusive global
32% YoY platform growth driven by record client engagement in list-based protocols Trumid, a financial technology company and leading fixed income electronic trading platform, today announced trade volume and user participation highlights for November 2025. https://mma.prnewswire.com/media/2544830/Trumid_Logo.jpg High Yield ADV rose 38% year-over-year, supported by elevated Trumid PT and Trumid Swarms activity November Highlights: Trumid sustained
Durable disease control and quality-of-life improvements for patients with ISM in the PIONEER trial — Prolonged survival, including in the first-line treatment setting, for patients with advanced SM in the PATHFINDER trial — Blueprint Medicines, aSanofi company, today announced updated data reinforcing the clinical efficacy and safety of long-term AYVAKIT®(avapritinib) use across the spectrum of
Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel small molecule modulators for oncology and autoimmune diseases, today announced the appointment of Daniel J. O'Connor as President & Chief Executive Officer, effective December 1, 2025. https://mma.prnewswire.com/media/2839402/Daniel_J_O_Connor_Jubilant.jpg Dan brings more than 30 years of leadership experience in biotechnology and oncology, with a proven track-record of creating
Strategic collaboration accelerates intelligence-driven Global Capability Centers bringing enterprise-grade processes, startup agility, and flexible workspaces Trigent, a leading technology solutions provider with over 30 years of engineering and custom software solution excellence, has entered into a strategic partnership with WeWork India, one of India's leading premium flexible workspace providers. The collaboration further strengthens Trigent's Global